Ralfkiaer N, Gatter K C, Alcock C, Heryet A, Ralfkiaer E, Mason D Y
Br J Cancer. 1985 Aug;52(2):167-70. doi: 10.1038/bjc.1985.173.
The practical usefulness of a panel of monoclonal antibodies recognising epithelial and lymphoid antigens has been evaluated on a series of 10 routinely processed thyroid tumours of uncertain origin. All 6 small cell tumours were shown to be of lymphoid origin whereas of the 4 large cell tumours two were lymphomas and two carcinomas. Two of the tumours, one large cell and one small cell, were undiagnosable due to technical reasons (crush artefact or small size of biopsy) and emphasized the value of immunohistology in this context. Clinical follow-up of all 10 cases indicated that these distinctions are of both prognostic and therapeutic value. It is concluded that immunocytochemistry using a carefully selected panel of monoclonal antibodies is a valuable and convenient means of making an objective distinction between anaplastic thyroid tumours of epithelial or lymphoid origin.
一组识别上皮和淋巴抗原的单克隆抗体在一系列10例来源不明的常规处理甲状腺肿瘤中的实际应用价值已得到评估。所有6例小细胞肿瘤均显示为淋巴源性,而4例大细胞肿瘤中,2例为淋巴瘤,2例为癌。其中2例肿瘤,1例大细胞肿瘤和1例小细胞肿瘤,由于技术原因(挤压伪像或活检样本过小)无法诊断,这凸显了免疫组织化学在此情况下的价值。对所有10例病例的临床随访表明,这些区分具有预后和治疗价值。结论是,使用精心挑选的单克隆抗体进行免疫细胞化学分析是一种有价值且便捷的方法,可用于客观区分上皮源性或淋巴源性间变性甲状腺肿瘤。